Status:
RECRUITING
EVEROLD LONG TERM FOLLOW-UP
Lead Sponsor:
University Hospital, Brest
Conditions:
Transplant; Complication, Failure
Eligibility:
All Genders
18+ years
Brief Summary
Long Term Follow up of EVEROLD study
Eligibility Criteria
Inclusion
- Informed patients participating to the EVEROLD study
- Patient having completed the EVEROLD M12 follow-up visit
- Patient agreeing to participate in the observational study
Exclusion
- Opposition to the use his medical data
- Patient under legal protection
Key Trial Info
Start Date :
August 23 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT06504225
Start Date
August 23 2024
End Date
August 1 2025
Last Update
February 6 2025
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Amiens
Amiens, France
2
CHU Bordeaux
Bordeaux, France
3
Chu Brest
Brest, France
4
CHU Lille
Lille, France